We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+9.29%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$8.2B
AUM Growth
+$637M
Cap. Flow
+$73.9M
Cap. Flow %
0.9%
Top 10 Hldgs %
20.74%
Holding
1,748
New
145
Increased
727
Reduced
671
Closed
102

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16.8M
2
VOD icon
Vodafone
VOD
+$12.3M
3
C icon
Citigroup
C
+$9.22M
4
MAG
MAG Silver
MAG
+$8.98M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$7.69M

Sector Composition

Rank Sector Weight
1 Technology 21.92%
2 Financials 10.53%
3 Industrials 8.25%
4 Consumer Discretionary 6.5%
5 Communication Services 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUJ icon
1501
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$640M
$224K ﹤0.01%
19,293
-13,072
-40% -$144K
ING icon
1502
ING
ING
$99.8B
$223K ﹤0.01%
+8,534
New +$206K
QQQH
1503
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$373M
$221K ﹤0.01%
4,065
+15
+0.4% +$801
MD icon
1504
Pediatrix Medical
MD
$2.17B
$220K ﹤0.01%
13,154
-3,500
-21% -$52.5K
NSP icon
1505
Insperity
NSP
$2.06B
$219K ﹤0.01%
4,456
GENI icon
1506
Genius Sports
GENI
$1.87B
$219K ﹤0.01%
17,700
+7,300
+70% +$87.3K
TR icon
1507
Tootsie Roll Industries
TR
$2.96B
$219K ﹤0.01%
+5,375
New +$203K
PD icon
1508
PagerDuty
PD
$800M
$218K ﹤0.01%
13,200
-5,800
-31% -$92.2K
LEG icon
1509
Leggett & Platt
LEG
$1.37B
$218K ﹤0.01%
24,501
CRNX icon
1510
Crinetics Pharmaceuticals
CRNX
$8.85B
$216K ﹤0.01%
+5,197
New +$166K
SDOG icon
1511
ALPS Sector Dividend Dogs ETF
SDOG
$1.41B
$216K ﹤0.01%
3,590
+17
+0.5% +$1K
CR icon
1512
Crane Co
CR
$12.4B
$215K ﹤0.01%
1,166
LQDH icon
1513
iShares Interest Rate Hedged Corporate Bond ETF
LQDH
$504M
$215K ﹤0.01%
+2,295
New +$213K
BIZD icon
1514
VanEck BDC Income ETF
BIZD
$1.6B
$214K ﹤0.01%
14,347
UBS icon
1515
UBS Group
UBS
$175B
$214K ﹤0.01%
5,225
-1,366
-21% -$53.1K
AGO icon
1516
Assured Guaranty
AGO
$3.73B
$214K ﹤0.01%
2,524
-51
-2% -$4.24K
FLG
1517
Flagstar Bank National Association
FLG
$5.94B
$214K ﹤0.01%
18,487
+45
+0.2% +$535
FTF
1518
Franklin Limited Duration Income Trust
FTF
$232M
$213K ﹤0.01%
33,502
+3,635
+12% +$23.3K
NMZ icon
1519
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.19B
$213K ﹤0.01%
20,132
+4,079
+25% +$41.6K
DSGX icon
1520
Descartes Systems
DSGX
$6.39B
$213K ﹤0.01%
2,261
-101
-4% -$10.3K
IBDY icon
1521
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
$1.09B
$213K ﹤0.01%
+8,110
New +$210K
TXG icon
1522
10x Genomics
TXG
$6.28B
$213K ﹤0.01%
+18,184
New +$237K
HLN icon
1523
Haleon
HLN
$44.5B
$212K ﹤0.01%
23,644
-267
-1% -$2.57K
H icon
1524
Hyatt Hotels
H
$16.6B
$212K ﹤0.01%
1,491
+8
+0.5% +$1.15K
AWR icon
1525
American States Water
AWR
$3.37B
$210K ﹤0.01%
+2,865
New +$213K

Similar funds

Oppenheimer & Co's Q3 2025 Portfolio in Review

As of Q3 2025, Oppenheimer & Co held 1,748 positions worth $8.2B, up 8.4% from $7.56B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Oppenheimer & Co's Q3 2025 filing shows 145 new, 727 increased, 671 reduced and 102 closed positions. Its largest new stake was SPDR Gold MiniShares Trust: 111,989 shares worth $8.56M. The largest sale was NVIDIA, an estimated $16.8M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q3 2025 buy was SPDR Gold MiniShares Trust: 111,989 shares worth $8.56M.
  • Oppenheimer & Co added most to AST SpaceMobile in Q3 2025, an estimated $8.33M increase.
  • Oppenheimer & Co's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $16.8M.
  • Oppenheimer & Co fully exited MAG Silver in Q3 2025, selling an estimated $8.98M.
  • Oppenheimer & Co's ten largest holdings make up 21% of its $8.2B portfolio in Q3 2025.
  • Oppenheimer & Co opened 145 new positions and closed 102 in Q3 2025.
  • Oppenheimer & Co's portfolio value rose 8.4% quarter-over-quarter to $8.2B.

Based on Oppenheimer & Co's 13F filing for Q3 2025, filed 6 Nov 2025.